BIOMAT Database Logo BIOMAT Database Logo

AIDS-related progressive multifocal leukoencephalopathy. 2020

Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Secretaria de Estado da Saúde de Goiás, Hospital de Doenças Tropicais Dr. Anuar Auad, Goiânia, GO, Brasil.

BACKGROUND Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by reactivation of JC virus (JCV). METHODS We described the profile of laboratory-confirmed PML cases among AIDS patients. RESULTS A total of 43 HIV patients with clinical conditions compatible with PML were obtained; 5 cases were confirmed by JCV testing. The main clinical finding was mental confusion. Median CD4 count was 54 cells/mm³. CONCLUSIONS Three of the five confirmed PML cases died; the time between diagnosis and death was 2, 5, and 6 months. It is important to consider JCV infection as a differential diagnosis.

UI MeSH Term Description Entries
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018791 CD4 Lymphocyte Count The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer. Lymphocyte Count, CD4,T4 Lymphocyte Count,CD4 Cell Counts,CD4 Counts,CD4+ Cell Counts,CD4+ Counts,CD4 Cell Count,CD4 Count,CD4 Lymphocyte Counts,CD4+ Cell Count,CD4+ Count,Count, T4 Lymphocyte,Counts, T4 Lymphocyte,Lymphocyte Count, T4,Lymphocyte Counts, CD4,Lymphocyte Counts, T4,T4 Lymphocyte Counts

Related Publications

Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
AIDS-related progressive multifocal leukoencephalopathy.
July 2005, Saudi medical journal,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Alpha Interferon in AIDS-Related Progressive Multifocal Leukoencephalopathy.
January 1996, Journal of neuro-AIDS,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
[Progressive multifocal leukoencephalopathy in AIDS].
March 1992, Nederlands tijdschrift voor geneeskunde,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Progressive multifocal leukoencephalopathy in AIDS.
August 1991, AIDS (London, England),
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Progressive multifocal leukoencephalopathy in AIDS.
July 1990, JAMA,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Progressive multifocal leukoencephalopathy (PML) in AIDS.
December 1988, Neurology,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Eculizumab-related progressive multifocal leukoencephalopathy.
January 2016, Neurology,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Progressive multifocal leukoencephalopathy in an AIDS patient.
March 2007, Journal of the Formosan Medical Association = Taiwan yi zhi,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
[Psoriasis and progressive multifocal leukoencephalopathy in AIDS].
October 1992, Revista clinica espanola,
Carolina de Oliveira Abrão, and Lissa Rodrigues Machado da Silva, and Luiz Carlos Silva Souza, and Nathalia de Mello Bisso, and Marília Dalva Turchi, and Adriana Oliveira Guilarde
Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.
December 2014, WMJ : official publication of the State Medical Society of Wisconsin,
Copied contents to your clipboard!